{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:08:42Z","timestamp":1793286522864,"version":"4.5.0"},"reference-count":58,"publisher":"Korean Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["e-dmj.org"],"crossmark-restriction":true},"short-container-title":["Diabetes Metab J"],"published-print":{"date-parts":[[2021,5,31]]},"DOI":"10.4093\/dmj.2020.0272","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T07:26:32Z","timestamp":1618817192000},"page":"326-336","update-policy":"https:\/\/doi.org\/10.4093\/crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus"],"prefix":"10.4093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-890X","authenticated-orcid":true,"given":"Jaehyun","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4800-943X","authenticated-orcid":true,"given":"Taegyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0542-2854","authenticated-orcid":true,"given":"Bong-Soo","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2567","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-1009-0"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1270-y"},{"key":"ref3","first-page":"12953","volume-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","author":"Lehmann","year":"1995"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01707.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1185\/030079906x112598"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa066224"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa072761"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.08.005"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17082-x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18274-1"},{"key":"ref11","volume-title":""},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.04.006"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2017.222"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103927"},{"key":"ref15","first-page":"900","volume-title":"Effects of three thiazolidinediones on metabolic regulation and cold-induced thermogenesis","author":"Sohn","year":"2018"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00539"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4292509"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.08.037"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7150\/thno.20885"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.11.1311"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/34184"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b07993"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00906"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2017.32.1.115"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2017.32.3.389"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0735"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4018"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/10590501.2012.735519"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s164840"},{"key":"ref30","first-page":"207","volume-title":"Carcinogenicity study of CKD-501, a novel dual peroxisome proliferator-activated receptors \u03b1 and \u03b3 agonist, following oral administration to Sprague Dawley rats for 94-101 weeks","author":"Lee","year":"2014"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2918"},{"key":"ref32","first-page":"1819","volume-title":"Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-\u03b3 agonist: a singleand multiple-dose, double-blind, randomized control study in healthy male Korean subjects","author":"Kim","year":"2011"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0197-y"},{"key":"ref34","first-page":"576","volume-title":"Pharmacokinetics of a lobeglitazone\/metformin fixed-dose combination tablet (CKD-395 0.5\/1000 mg) versus concomitant administration of single agents and the effect of food on the metabolism of CKD-395 in healthy male subjects","author":"Kim","year":"2019"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.703131"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.01.003"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.04.005"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.06.009"},{"key":"ref39","first-page":"737","volume-title":"Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-\u03b3 agonist, on the pharmacokinetics and pharmacodynamics of warfarin","author":"Jung","year":"2015"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.05.064"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092843"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.09.009"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12435"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14085"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2017.11.005"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000807"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.11.1605"},{"key":"ref48","first-page":"1074","volume-title":"A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-na\u00efve patients with type 2 diabetes mellitus","author":"Herz","year":"2003"},{"key":"ref49","first-page":"6068","volume-title":"Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial","author":"Schernthaner","year":"2004"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01426.x"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00820.x"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.001"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.1.60"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200108000-00011"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2165\/00024677-200201050-00005"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(04)90068-9"},{"key":"ref57","first-page":"85","volume-title":"Pioglitazone: a review of its use in type 2 diabetes mellitus","author":"Waugh","year":"2006"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2017.41.5.377"}],"container-title":["Diabetes & Metabolism Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.e-dmj.org\/upload\/pdf\/dmj-2020-0272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.e-dmj.org\/journal\/view.php?doi=10.4093\/dmj.2020.0272","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-dmj.org\/upload\/pdf\/dmj-2020-0272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T21:45:24Z","timestamp":1645739124000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.e-dmj.org\/journal\/view.php?doi=10.4093\/dmj.2020.0272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.4093\/dmj.2020.0272","relation":{},"ISSN":["2233-6079","2233-6087"],"issn-type":[{"value":"2233-6079","type":"print"},{"value":"2233-6087","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"2020-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-19","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-31","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}